Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia

Carolyn M. Larsen, Hector R Vilarraga, Kebede Begna, Mark R Litzow, Aref Al-Kali, Joerg Herrmann

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia'. Together they form a unique fingerprint.